Glucosamine conjugated iron oxide and graphene oxide nanohybrid for smart drug delivery

Smart drug delivery systems have attracted a lot of attention as one of the new treatment methods for cancer. In this study, a smart drug delivery system carrying anticancer drugs was obtained by the intelligent synthesis of glucosamine (GA)-functionalized graphene oxide (GO)-based iron oxide nanoparticles (Fe₃O₄@GO-GA) using Hummers and chemical co-precipitation processes. Nanohybrids have a high surface area (280.26 m²/g) and superparamagnetic behaviour (Ms = 26.017 emu/g), indicating a significant loading capacity (373.78 mg/mg) and efficiency (96.3%) for pharmaceutical loading. An adsorption study of conventional daunorubicin (DNR) on this carrier showed that the drug release is more prone to occur under acidic conditions (pH = 5.5), at moderately high temperatures (T = 40°C), and in the absence of smart carriers. The toxicity of the smart nanohybrids was examined using the sulphorhodamine B (SRB) assay in Michigan Cancer Foundation-7 (MCF-7) cell lines. The rate of death of cells exposed to smart drug-containing systems in comparison to the systems without GA shows that GA reduces the toxicity of Fe₃O₄@GO.